Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122413) titled 'Analysis of Efficacy and Safety of Tocilizumab in Elderly Women with Refractory Rheumatoid Arthritis' on April 13.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Yuebei People's Hospital
Condition:
Rheumatoid arthritis
Intervention:
Tocilizumab Treatment Group Intervention: Participants received tocilizumab (dose calculated based on body weight) in combination with methotrexate (10-15 mg/week, at a stable dose) and prednisone ( <= 7.5 mg/day, with a plan for tapering within 4 weeks after enrollment).:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First E...